Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) Return on Equity (2020 - 2025)

Benitec Biopharma has reported Return on Equity over the past 6 years, most recently at 0.0% for Q4 2025.

  • Quarterly results put Return on Equity at 0.0% for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was 0.0% (changed 0.0% YoY), and the annual figure for FY2025 was 0.01%, changed 0.0%.
  • Return on Equity reached 0.0% in Q4 2025 per BNTC's latest filing, up from 0.0% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.0% in Q2 2025 and bottomed at 0.08% in Q2 2023.
  • Median Return on Equity over the past 5 years was 0.01% (2021), compared with a mean of 0.01%.
  • The largest annual shift saw Return on Equity fell -4bps in 2023 before it increased 7bps in 2024.
  • Over 5 years, Return on Equity stood at 0.01% in 2021, then dropped by -19bps to 0.02% in 2022, then rose by 26bps to 0.01% in 2023, then soared by 114bps to 0.0% in 2024, then plummeted by -254bps to 0.0% in 2025.
  • Business Quant data shows Return on Equity for BNTC at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.